by Eric Christianson | Oct 24, 2018 | Writing Medication Recommendations For Pharmacists
I have a deep passion for trying to provide value while working as a clinical pharmacist. I had a couple of negative experiences with providers when I first graduated. From those poor recommendations and negative responses from the providers, my strategy has always...
by Eric Christianson | Oct 17, 2018 | Medication and Disease State Clinical Pearls For Pharmacists, Psychiatry and Addiction Medication and Disease State Clinical Pearls
I’ve covered many potential adverse effects and clinical quirks with the SSRI’s on this podcast, but one mystery still remains. What to do about the SSRI platelet inhibition effect? The SSRI platelet inhibition effect is a real clinical conundrum. If...
by Eric Christianson | Oct 10, 2018 | Medication and Disease State Clinical Pearls For Pharmacists, Pharmacogenomics and Pharmacokinetics Medication and Disease State Clinical Pearls
What the heck is HLA B*5701? Let’s start with the HLA. HLA stands for human leukocyte antigen. The rest of the name is simply indicating that it is subtype of HLA. There are many different subtypes of HLA as mentioned with each specific medication below. You...
by Eric Christianson | Oct 3, 2018 | Personal Stories From The Front Lines of Clinical Pharmacy
Fear of putting myself out there has always been challenging for me. It is something that I try to work at on a daily basis. Whether it be speaking engagements, new educational opportunities, or simply attempting to contact some by email, these are hurdles where...
by Eric Christianson | Sep 30, 2018 | Drug Interaction Case Studies and Education For Pharmacists
Here I will discuss the propranolol and ciprofloxacin interaction by presented a brief case scenario. A 59 year old female with a 40 year history of smoking a pack per day presents today, complaining of worsening respiratory status. She is having a lot of dyspnea. ...
